Medtronic Expands Its ENT Portfolio With Intersect ENT Acquisition For $28.25/Share
Medtronic plc (NYSE:MDT) has agreed to acquire Intersect ENT Inc (NASDAQ:XENT) for $28.25 per share in an all-cash transaction implying an enterprise…
Understanding Medtronic’s Unusual Options Activity
On Wednesday, shares of Medtronic (NYSE:MDT) saw unusual options activity. After the option alert, the stock price moved down to $128.82.
Medtronic’s Antibacterial Envelope Effective In Reducing Infections In Cardiac Device Patients With Hematomas
Medtronic plc (NYSE:MDT) has announced new data from the WRAP-IT study published in Heart Rhythm. The study evaluated Tyrx absorbable antibacterial…
Medtronic Reports Its Absorbable Antibacterial Envelope Is Effective At Reducing Infections In Cardiac Device Patients With Hematomas
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced new data from the landmark WRAP-IT study published in Heart Rhythm, demonstrating a significantly lower infection risk for patients who
Analyzing Medtronic’s Unusual Options Activity
On Tuesday, shares of Medtronic (NYSE:MDT) saw unusual options activity. After the option alert, the stock price moved up to $125.7.
Medtronic’s Palliare announces US FDA 510(k) clearance to extend the indications of its EVA15 insufflation technology for use in endoscopic surgery
Palliare, an emerging company with the vision to create a safer operating room, today announced that it has received FDA 510(k) clearance for its END-200 tubeset, which extends the capabilities of its EVA15 continuous
Mayo Clinic Purchases BioSig’s PURE EP™ for use at its Phoenix Location
According to a recently filed 8-k, BioSig Technologies, Inc. (NASDAQ: BSGM) received a new purchase order from the Mayo Foundation for medical education and research.
Titan Medical: Innovation Leader in Robotic-assisted, Single Access Surgery Technology
Robotic-assisted single access surgery might sound like a future pipe dream for the medical community, but the technology exists today, and Titan Medical Inc. (NASDAQ: TMDI; TSX: TMD) is paving the way to bringing its exciting technology to surgeons.
Medtronic Highlights InPen Data Presentation At 81st Annual American Diabetes Association Scientific Sessions
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced key clinical data from the virtual 81st annual American Diabetes Association Scientific Sessions. The presentations
United Therapeutics And Medtronic Discontinue Further Efforts To Develop & Commercialize Implantable System For Remodulin Based On Evolution Of Treatment Options, Paradigms In Pulmonary Arterial Hypertension Over Past Few Years
On June 22, 2021, United Therapeutics Corporation (the “Company”) and Medtronic, Inc. (“Medtronic”) agreed to discontinue further efforts to develop and commercialize the Implantable